Displaying 1101 - 1120 of 4736
Axon Enterprise, Inc. and Safariland, LLC; Analysis of Consent Order To Aid Public Comment
FTC Approves Final Order Settling Charges that Merger of Polyurethane Foam Producers Was Anticompetitive
FXI Holdings and Innocor, In the Matter of
Polyurethane foam producers FXI Holdings, Inc. and Innocor, Inc. have agreed to divest polyurethane foam pouring plants in three regional markets to Future Foam, Inc., to settle Federal Trade Commission charges that FXI’s proposed $850 million acquisition of Innocor would violate federal antitrust law. The FTC alleges that the combination of FXI and Innocor would substantially lessen competition for low-density conventional polyurethane foam used in home furnishings in three regional markets: the Pacific Northwest (Oregon and Washington); the Midwest states of Indiana, Michigan, and Ohio; and Mississippi. To remedy the proposed transaction’s anticompetitive effects, the proposed order requires the companies to divest FXI’s foam-pouring plant in Kent, Washington and Innocor’s foam-pouring plants in Elkhart, Indiana and Tupelo, Mississippi to Future Foam no later than 10 days after the close of the acquisition. On April 20, 2020, the Commission voted 5-0 to approve the final order settling the charges.
VieVu’s Former Parent Company Safariland Agrees to Settle Charges That It Entered into Anticompetitive Agreements with Body-Worn Camera Systems Seller Axon
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules (March 2020)
Six More States Join FTC and NY Attorney General’s Case Against Vyera Pharmaceuticals, Martin Shkreli, and Other Defendants
Federal Trade Commission and Justice Department Issue Joint Statement Announcing They are on Alert for Collusion in U.S. Labor Markets
2004002 Informal Interpretation
FTC Approves Final Order Imposing Conditions on Veterinary Service Providers Compassion First and National Veterinary Associates
Federal Trade Commission Closes Investigation of Johnson & Johnson’s Proposed Acquisition of TachoSil from Takeda Pharmaceutical Company
Össur Hf.; Analysis of Agreement Containing Consent Order To Aid Public Comment
Agnaten SE, Compassion First, and NVA, In the Matter of
Veterinary service providers Compassion First and National Veterinary Associates, or NVA, have agreed to divest facilities in three locations to MedVet Associates, LLC, to settle Federal Trade Commission charges that Compassion First’s proposed $5 billion acquisition of NVA would violate federal antitrust law. According to the complaint, as proposed, the acquisition would harm competition in and around Asheville, N.C., and Greenville, S.C.; between Norwalk, Conn., and Yonkers, N.Y.; and in and around Fairfax and Manassas, Va. for various specialty and emergency veterinary services, by eliminating close, head-to-head competition between the parties. Under the proposed settlement agreement, the order requires Compassion First and NVA to divest one clinic in each of the three geographic markets.
FTC Imposes Conditions on Össur Hf’s Acquisition of College Park Industries, Inc.
Statement of Commissioner Rohit Chopra Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Altria Group, Inc. and JUUL Labs, Inc.
2004003 Informal Interpretation
2004001 Informal Interpretation
FTC Sues to Unwind Altria’s $12.8 Billion Investment in Competitor JUUL
FTC Announces September 22 Workshop on Data Portability
Displaying 1101 - 1120 of 4736